欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3457/001
药品名称Palonosetron Fresenius Kabi
活性成分
    • palonosetron hydrochloride 250.0 µg
剂型Solution for injection
上市许可持有人Fresenius Kabi Deutschland GmbH
参考成员国 - 产品名称Netherlands (NL)
Palonosetron Fresenius Kabi 250 microgram, oplossing voor injectie
互认成员国 - 产品名称
    • Germany (DE)
      Palonosetron Fresenius Kabi 250 Mikrogramm Injektionslösung
    • Denmark (DK)
      Palonosetron Fresenius Kabi
    • Belgium (BE)
      Palonosetron Fresenius Kabi
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Greece (GR)
      PALONOSETRON/FRESENIUS KABI
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Palonosetron Fresenius Kabi
    • Finland (FI)
    • Czechia (CZ)
      PALONOSETRON FRESENIUS KABI 250 MIKROGRAMŮ INJEKČNÍ ROZTOK
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
      Palonosetron Fresenius Kabi 250 mikrogramov raztopina za injiciranje
    • Malta (MT)
      Palonosetron Fresenius Kabi 250 micrograms, solution for Injection
许可日期2016/05/26
最近更新日期2022/05/25
药物ATC编码
    • A04AA05 palonosetron
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase